Literature DB >> 27356835

Familial Adenomatous Polyposis; Succesful Use of Sirolimus.

Hasan Yuksekkaya1, Aylin Yucel1, Meltem Gumus2, Hasan Esen3, Hatice Toy3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27356835     DOI： 10.1038/ajg.2016.159

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.

Authors:  Cassandra R Diegel; Kathleen R Cho; Adel K El-Naggar; Bart O Williams; Charlotta Lindvall
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

2.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.

Authors:  Kenneth E Hung; Marco A Maricevich; Larissa Georgeon Richard; Wei Y Chen; Michael P Richardson; Alexandra Kunin; Roderick T Bronson; Umar Mahmood; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

3.  Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.

Authors:  Teruaki Fujishita; Koji Aoki; Heidi A Lane; Masahiro Aoki; Makoto M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

4.  Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.

Authors:  Karin M Hardiman; Jianhua Liu; Ying Feng; Joel K Greenson; Eric R Fearon
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

Review 5.  Familial adenomatous polyposis.

Authors:  Elizabeth Half; Dani Bercovich; Paul Rozen
Journal:  Orphanet J Rare Dis       Date:  2009-10-12       Impact factor: 4.123
  5 in total
  4 in total

1.  Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study.

Authors:  Teresa M Neuhann; Katharina Haub; Verena Steinke-Lange; Monika Morak; Andreas Laner; Melanie Locher; Elke Holinski-Feder
Journal:  Fam Cancer       Date:  2022-05-16       Impact factor: 2.375

2.  MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.

Authors:  John R P Knight; Constantinos Alexandrou; George L Skalka; Nikola Vlahov; Kathryn Pennel; Leah Officer; Ana Teodosio; Georgios Kanellos; David M Gay; Sebastian May-Wilson; Ewan M Smith; Arafath K Najumudeen; Kathryn Gilroy; Rachel A Ridgway; Dustin J Flanagan; Rachael C L Smith; Laura McDonald; Craig MacKay; Anne Cheasty; Kerri McArthur; Emma Stanway; Joshua D Leach; Rene Jackstadt; Joseph A Waldron; Andrew D Campbell; Georgios Vlachogiannis; Nicola Valeri; Kevin M Haigis; Nahum Sonenberg; Christopher G Proud; Neil P Jones; Martin E Swarbrick; Heather J McKinnon; William J Faller; John Le Quesne; Joanne Edwards; Anne E Willis; Martin Bushell; Owen J Sansom
Journal:  Cancer Discov       Date:  2020-12-16       Impact factor: 38.272

Review 3.  Chemoprevention in familial adenomatous polyposis: past, present and future.

Authors:  Phillip M Kemp Bohan; Gautam Mankaney; Timothy J Vreeland; Robert C Chick; Diane F Hale; Jessica L Cindass; Annelies T Hickerson; Daniel C Ensley; Vance Sohn; G Travis Clifton; George E Peoples; Carol A Burke
Journal:  Fam Cancer       Date:  2020-06-08       Impact factor: 2.375

4.  Rpl24Bst mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K.

Authors:  John Rp Knight; Nikola Vlahov; David M Gay; Rachel A Ridgway; William James Faller; Christopher Proud; Giovanna R Mallucci; Tobias von der Haar; Christopher Mark Smales; Anne E Willis; Owen J Sansom
Journal:  Elife       Date:  2021-12-13       Impact factor: 8.140
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.